Posts Tagged ‘CRME’

LZR merges, MSFT moving, CRME skips a beat

Monday, February 7th, 2011

Emergent Group Inc. (AMEX: LZR) shares sprang up 38.8 per cent to $8.41, on volume of 284,325 or more than 11 times its daily average. Monday, it was announced that LZR was to be acquired by Universal Hospital Services for $8.46 a share.

Microsoft Inc. (Nasdaq: MSFT) traded in 25.3 million shares, pursuing a daily average of 58.4 million. Share prices added 1.6 percent to $28.22, amid general momentum in the tech world.

Cardiome Pharma Corporation (Nasdaq: CRME) lost 11.4 percent Monday to $6.06. Volume was 561,971 shares, nearly twice its normal daily average. Vancouver-based CRME is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system.